Dataset Information


White opioids: Pharmaceutical race and the war on drugs that wasn't.

ABSTRACT: The US 'War on Drugs' has had a profound role in reinforcing racial hierarchies. Although Black Americans are no more likely than Whites to use illicit drugs, they are 6-10 times more likely to be incarcerated for drug offenses. Meanwhile, a very different system for responding to the drug use of Whites has emerged. This article uses the recent history of White opioids - the synthetic opiates such as OxyContin® that gained notoriety starting in the 1990s in connection with epidemic prescription medication abuse among White, suburban and rural Americans and Suboxone® that came on the market as an addiction treatment in the 2000s - to show how American drug policy is racialized, using the lesser known lens of decriminalized White drugs. Examining four 'technologies of whiteness' (neuroscience, pharmaceutical technology, legislative innovation and marketing), we trace a separate system for categorizing and disciplining drug use among Whites. This less examined 'White drug war' has carved out a less punitive, clinical realm for Whites where their drug use is decriminalized, treated primarily as a biomedical disease, and where their whiteness is preserved, leaving intact more punitive systems that govern the drug use of people of color.

SUBMITTER: Netherland J 

PROVIDER: S-EPMC5501419 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC4253601 | BioStudies
1000-01-01 | S-EPMC3020681 | BioStudies
2006-01-01 | S-EPMC1621100 | BioStudies
2015-01-01 | S-EPMC4404217 | BioStudies
2013-01-01 | S-EPMC4000530 | BioStudies
2016-01-01 | S-EPMC4983522 | BioStudies
2015-01-01 | S-EPMC4415060 | BioStudies
2020-01-01 | S-EPMC7825250 | BioStudies
2011-01-01 | S-EPMC3395319 | BioStudies
2018-01-01 | S-EPMC6249016 | BioStudies